Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.25.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance, Shares at Dec. 31, 2023   22,604,676      
Beginning balance at Dec. 31, 2023 $ 37,784 $ 2 $ 477,624 $ (4,556) $ (435,286)
Release of Restricted Stock Units and Performance Stock Units, Shares   907,182      
Issuance of common stock under Employee Stock Purchase Plan, Share   79,903      
Issuance of common stock under Employee Stock Purchase Plan 370   370    
Exercise of stock options, Shares   37,758      
Exercise of stock options 269   269    
Stock compensation expense 13,382   13,382    
Issuance of common stock under the Securities Purchase Agreements, net, Shares   2,976,191      
Issuance of common stock under the Securities Purchase Agreements, net, Value 37,882 $ 1 37,881    
Net (loss) income (54,576)       (54,576)
Foreign currency translation adjustments (4,275)     (4,275)  
Net unrealized loss on investments (net of tax) 2     2  
Ending balance, shares at Sep. 30, 2024   26,605,710      
Ending balance at Sep. 30, 2024 30,838 $ 3 529,526 (8,829) (489,862)
Beginning balance, Shares at Jun. 30, 2024   26,283,274      
Beginning balance at Jun. 30, 2024 40,334 $ 3 524,567 (6,847) (477,389)
Release of Restricted Stock Units and Performance Stock Units, Shares   322,436      
Stock compensation expense 4,959   4,959    
Net (loss) income (12,473)       (12,473)
Foreign currency translation adjustments (1,986)     (1,986)  
Net unrealized loss on investments (net of tax) 4     4  
Ending balance, shares at Sep. 30, 2024   26,605,710      
Ending balance at Sep. 30, 2024 30,838 $ 3 529,526 (8,829) (489,862)
Beginning balance, Shares at Dec. 31, 2024   27,218,490      
Beginning balance at Dec. 31, 2024 (11,687) $ 3 536,725 (9,770) (538,645)
Release of Restricted Stock Units and Performance Stock Units, Shares   1,195,091      
Issuance of common stock under Employee Stock Purchase Plan, Share   50,266      
Issuance of common stock under Employee Stock Purchase Plan $ 443   443    
Exercise of stock options, Shares 241,132 241,132      
Exercise of stock options $ 1,824   1,824    
Stock compensation expense 14,957   14,957    
Issuance of common stock under the Securities Purchase Agreements, net, Shares   4,843,750      
Issuance of common stock under the Securities Purchase Agreements, net, Value 36,047   36,047    
Exercise of warrants, shares   673,146      
Exercise of warrants, value 11,592   11,592    
Net (loss) income 76,399       76,399
Foreign currency translation adjustments 3,526     3,526  
Net unrealized loss on investments (net of tax) 28     28  
Ending balance, shares at Sep. 30, 2025   34,221,875      
Ending balance at Sep. 30, 2025 133,129 $ 3 601,588 (6,216) (462,246)
Beginning balance, Shares at Jun. 30, 2025   33,743,329      
Beginning balance at Jun. 30, 2025 149,234 $ 3 596,804 (5,003) (442,570)
Release of Restricted Stock Units and Performance Stock Units, Shares   342,955      
Exercise of stock options, Shares   135,591      
Exercise of stock options 954   954    
Stock compensation expense 3,830   3,830    
Net (loss) income (19,676)       (19,676)
Foreign currency translation adjustments (1,244)     (1,244)  
Net unrealized loss on investments (net of tax) 31     31  
Ending balance, shares at Sep. 30, 2025   34,221,875      
Ending balance at Sep. 30, 2025 $ 133,129 $ 3 $ 601,588 $ (6,216) $ (462,246)